thirty day period with next-line medicines Employed in the shorter MDR-TB routine or in whom resistance to fluoroquinolones and next-line injectable agents continues to be excluded, a shorter MDR-TB routine of 9??12??months may very well be utilised rather than the extended regimens (Conditional recommendation, lower certainty within the estimates